Benjamin Garmezy
Benjamin Garmezy publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment and Prostate Cancer Treatment and Research.
- World rank
- #2,956,840 of 7,710,434 ranked researchers
- Rank in United States
- #850,921 of 1,627,098
- Works
- 98
- Citations
- 487
- Citations per work
- 5.0
What does Benjamin Garmezy research?
Benjamin Garmezy's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4848.8%
- Medicine4848.8%
- Everything else2525.9%
- Life Sciences2525.3%
- 1Oncology21% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Molecular Biology14% of their works
- 4Surgery8% of their works
- 5Cancer Research7% of their works
- 6Immunology4% of their works
Research topics
Which keywords describe Benjamin Garmezy's research?
The keywords of their largest research topics: Immunotherapy, Genetic Mutations, Molecular Characterization, Therapy, Immune Checkpoint Blockade, Metastatic, PD-1 and PD-L1 and Renal Cell Carcinoma.
- Histone Modification
- FGF21
- Chimeric Antigen Receptor
- Urothelial Carcinoma
- Cancer Genomics
- Prostate Cancer
- Renal Cell Carcinoma
- Metastatic
- Therapy
- Genetic Mutations
- Immunotherapy
- Molecular Characterization
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Androgen Receptor
- Bladder Cancer
- Mutational Signatures
- CAR T Cells
- DNA Methylation
- Fibroblast Growth Factor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Immunotherapy344 topics
- Genetic Mutations222 topics
- Molecular Characterization212 topics
- Therapy192 topics
- Immune Checkpoint Blockade141 topic
- Metastatic141 topic
- PD-1 and PD-L1141 topic
- Renal Cell Carcinoma141 topic
- Androgen Receptor81 topic
- Prostate Cancer81 topic
- Bladder Cancer71 topic
- Cancer Genomics71 topic
- Mutational Signatures71 topic
- Urothelial Carcinoma71 topic
- CAR T Cells51 topic
- Chimeric Antigen Receptor51 topic
- DNA Methylation51 topic
- FGF2151 topic
- Fibroblast Growth Factor51 topic
- Histone Modification51 topic
Where does Benjamin Garmezy work?
Benjamin Garmezy's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Benjamin Garmezy have?
OpenAlex counts 98 works and 487 citations for Benjamin Garmezy, an h-index of 11, ranking #2,956,840 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Benjamin Garmezy
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Benjamin Garmezy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.